A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

NCT05344469 · clinicaltrials.gov ↗

RECRUITING

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

OTHER: ofatumumab
OTHER: glatiramer acetate
OTHER: interferon β1
OTHER: teriflunomide
OTHER: dimethyl fumarate (DMF)
OTHER: diroximel fumarate (DRF)

Sponsor

Novartis Pharmaceuticals